GC tissues; paired nontumor tissues; serum; serum exosomes; xenograft tumor tissues
N87; HGC27; AGS; MKN-45; GES-1
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); glycolysis (promotes); metastasis (promotes)
RT-qPCR; Clinical Sample Validation; Transfection; Colony Formation Assay; EdU Staining; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; RNA Pull-Down; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); In Vivo Animal Model; Bioinformatics Analysis
High circKIAA1797 expression was associated with TNM stage and H. pylori-infection, and exosomal circKIAA1797 may be a potential therapeutic target for GC.
Exosomal circKIAA1797 is up-regulated in gastric cancer tissues, cells, and serum-derived exosomes. It promotes GC malignant phenotypes, glycolysis, and tumor growth by sponging miR-4429 and up-regulating PBX3, while its knockdown suppresses proliferation, migration, invasion, glycolytic metabolism and enhances apoptosis. The study suggests exosomal circKIAA1797 as a potential therapeutic target for GC.
0.7294
Exosomal circKIAA1797 Regulates Cell Progression and Glycolysis by Targeting miR-4429/PBX3 Pathway in Gastric Cancer.
combined biological and clinical study